Anti-aging biotech: past, present and futureAuthor: Phil Newman | Published on: April 28, 2020 | Last updated: May 10, 2022 Joao Pedro de MagalhaesSenior Lecturer, University of LiverpoolAnti-aging biotech: past, present and futureShare this article: Editor's choiceEmpowering cells to boost energy and recovery is a winning moveStudy disproves benefits of probiotics for vaginal healthHow do Tour De France athletes recover so fast? Performance coach reveals the secret9 proven ways to beat brain fog and enhance your energyLongevity investment platform opens-up to international investorsUrolithin A research opens door to osteoarthritis relief Popular articlesLongevity Biomedical and SPAC Denali to create Nasdaq-listed longevity biopharm companyA decade of research expands the Hallmarks of Aging from nine to twelveLongevity investment bulletin: Juvena, eGenesis, Springs Rejuvenation and morePetr Sramek: Now is the right time to invest in longevityResearchers identify small molecule that restores visual function after optic nerve injuryHypertension drug rilmenidine can extend lifespan and slow aging
